ArticlePest management science2026
1,2,4-Triazolium compounds as anti-oomycete leads against Phytophthora capsici.
Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
background1,2,4-Triazolium salts are a class of stable heterocyclic salts widely used as in situ carbene precursors in organic synthesis, and they have also been reported to exhibit favorable physicochemical properties and diverse biological activities. This study aims to elucidate the potential of 1,2,4-triazolium salts as antifungal and anti-oomycete agents.
resultsIn this study, a series of 1,2,4-triazolium derivatives were evaluated for their inhibitory activities against phytopathogenic oomycete Phytophthora capsici. Compound 42 displayed the most potent in vitro activity against P. capsici, with a half-maximal effective concentration (EC
conclusionOur results establish 1,2,4-triazolium compound 42 as a promising scaffold for the future development of anti-oomycete agents, offering a potential molecular basis for the design of novel crop protectants against P. capsici. © 2026 Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.